Apolipoprotein-E modulates the cytotoxic effect of β-amyloid on rat brain endothelium in an isoform-dependent specific manner

International Journal of Molecular Medicine

Volumn 17, Issue 5, 2006, Pages 821-826

  Folin, Marcella ^a   Baiguera, Silvia ^a   Guidolin, Diego ^a   Di Liddo, Rosa ^a   Grandi, Claudio ^a   De Carlo, Eugenio ^a   Nussdorfer, Gastone G ^a   Parnigotto, Pier Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apolipoprotein E; Brain endothelial cells; In vitro angiogenesis; Rat; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; PEPTIDE FRAGMENT;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; MALE; METABOLISM; OXIDATION REDUCTION REACTION; RAT; SPRAGUE DAWLEY RAT;

AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33750576450     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.5.821     Document Type: Article

References (43)

1. Selkoe DJ: The molecular pathology of Alzheimer's disease. Neuron 6: 487-498, 1991.
2. Selkoe DJ: Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol 4: 708-716, 1994. (Pubitemid 24325314)
3. Kosik KS: Alzheimer's disease: a cell biological perspective. Science 256: 78780-78783, 1992.
4. Sisodia SS and Price DL: Role of the beta-amyloid protein in Alzheimer's disease. FASEB J 9: 366-370, 1995.
5. Weisgraber KH, Roses AD and Strittmatter WJ: The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 5: 110-116, 1994.
6. Wisniewski T, Golabek AA, Kida E, Wisniewski KE and Frangione B: Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol 147: 238-244, 1995.
7. Mahley RW, Innerarity TL, Rall SC, Weisgraber KH and Taylor JM: Apolipoprotein E genetic variants provide insights into its structure and function. Curr Opin Lipidol 1: 87-95, 1990.
8. Folin M, Baiguera S, Conconi MT, DiLiddo R, DeCarlo E, Parnigotto PP and Nussdorfer GG: Apolipoprotein E as vascular risk factor in neurodegenerative dementia. Int J Mol Med 14: 609-613, 2004.
9. Evans KC, Berger EP, Cho CG, Weisgraber KH and Lansbury PT Jr: Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92: 763-767, 1995.
10. Pillot T, Goethals M, Vanloo B, Lins L, Brasseur R, Vandekerckhove J and Rosseneu M: Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms. Eur J Biochem 243: 650-659, 1997.
11. Russo C, Angelini G, Dapino D, Piccini A, Piombo G, Schettini G, Chen S, Teller JK, Zaccheo D, Gambetti P and Tabaton M: Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proc Natl Acad Sci USA 95: 15598-15602, 1998.
12. Bales KR, Dodart JC, DeMattos RB, Holtzman DM and Paul SM: Apolipoprotein E, amyloid, and Alzheimer disease. Mol Interv 2: 363-375, 2002.
13. Strittmatter WJ, Sauders AM, Schmechel D, Pericak-Vance M, Enghild J, Salversen GS and Roses AD: Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90: 1977-1981, 1993.
14. Strittmatter WJ, Weisgraber KH, Haung DY, Dong LM, Salversen GS, Pericak-Vance M, Schmechel D, Sauders AM, Goldgaber D and Roses AD: Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90: 8098-8102, 1993. (Pubitemid 23260862)
15. Wisniewski T, Golabek A, Matsubara E, Ghiso J and Frangione B: Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 192: 359-365, 1993.
16. Skoog I, Hesse C, Fredman P, Andreasson LA, Palmertz B and Blenow K: Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Arch Neurol 54: 267-272, 1997.
17. Ma J, Brewer HB Jr and Potter H: Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides. Neurobiol Aging 17: 773-780, 1996.
18. Miyata M and Smith JD: Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14: 55-61, 1996.
19. Jordan J, Galindo MF, Miller RJ, Reardon CA, Getz GS and La Du MJ: Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 18: 195-204, 1998.
20. Drouet B, Fifre A, Pincon-Raymond M, Vandekerckhove J, Rosseneu M, Gueant JL, Chambaz J and Pillot T: ApoE protects cortical neurones against neurotoxicity induced by the nonfibrillar C-terminal domain of the amyloid-beta peptide. J Neurochem 76: 117-127, 2001.
21. Folin M, Baiguera S, Conconi MT, Pati T, Grandi C, Parnigotto PP and Nussdorfer GG: The impact of risk factors of Alzheimer's disease in the Down syndrome. Int J Mol Med 11: 267-270, 2003.
22. Folin M, Baiguera S, Tommasini M, Guidolin D, Conconi MT, DeCarlo E, Nussdorfer GG and Parnigotto PP: Effects of β-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int J Mol Med 15: 929-935, 2005.
23. Folin M, Baiguera S, Fioravanzo S, Conconi MT, Grandi C, Nussdorfer GG and Parnigotto PP: Caspase-8 activation and oxidative stress are involved in the cytotoxic effect of β-amyloid on rat brain microvascular endothelial cells. Int J Mol Med (In press).
24. Abbott NJ, Hughes CCW, Revest PA and Greenwood J: Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci 103: 23-37, 1992.
25. Baiguera S, Conconi MT, Guidolin D, Mazzocchi G, Malendowicz LK, Parnigotto PP, Spinazzi R and Nussdorfer GG: Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int J Mol Med 14: 849-854, 2004.
26. Conconi MT, Lora S, Baiguera S, Boscolo E, Folin M, Scienza R, Rebuffat P, Parnigotto PP and Nussdorfer GG: In vitro culture of rat neuromicrovascular endothelial cells on polymeric scaffolds. J Biomed Mater Res 71: 669-674, 2004.
27. Mossman T: Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
28. Ribatti D, Guidolin D, Conconi MT, Nico B, Baiguera S, Parnigotto PP, Vacca A and Nussdorfer GG: Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene 22: 6458-6461, 2003.
29. Wisniewski T and Frangione B: Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135: 235-238, 1992.
30. Stratman NC, Castle CK, Taylor BM, Epps DE, Melchior GW and Carter DB: Isoform specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide. Chem Phys Lipids 137: 52-61, 2005.
31. Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C and Frangione B: Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J 306: 599-604, 1995.
32. Soto C, Castano EM, Prelli F, Kumar RA and Baumann M: Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett 371: 110-114, 1995.
33. Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B and Paul SM: Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 96: 15233-15238, 1999.
34. Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM and Paul SM: Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 102: 1211-1216, 2005.
35. Wilhelmus MM, Otte-Holler I, Davis J, van Nostrand WE, DeWaal RM and Verbeek MM: Apolipoprotein E genotype regulates amyloid-β cytotoxicity. J Neurosci 25: 3621-3627, 2005.
36. La Du MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS and Frail DE: Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269: 23403-23406, 1994.
37. La Du MJ, Lukens JR, Reardon CA and Getz GS: Association of human, rat, and rabbit apolipoprotein E with beta-amyloid. J Neurosci Res 49: 9-18, 1997.
38. Pillot T, Goethals M, Najib J, Labeur C, Lins L, Chambaz J, Brasseur R, Vandekerckhove J and Rosseneu M: Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease. J Neurochem 72: 230-237, 1999.
39. Lee G, Pollard HB and Arispe N: Annexin 5 and apolipoprotein E2 protect against Alzheimer's amyloid-β-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site. Peptides 23: 1249-1263, 2002.
40. Pillot T, Goethals M, Vanloo B, Talussot C, Brasseur R, Rosseneu M, Vandekerckhove J and Lins L: Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. J Biol Chem 271: 28757-28765, 1996.
41. Takashima A, Noguchi K, Michel G, Mercken M, Hoshi M, Ishiguro K and Imahori K: Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci Lett 203: 33-36, 1996.
42. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, Akterin S, Pei JJ, Winblad B and Cowburn RF: Apolipoprotein E and beta-amyloid(1-42) regulation of glycogen synthase kinase-3beta. J Neurochem 87: 1152-1164, 2003.
43. Paris D, Patel N, DelleDonne A, Quadros A, Smeed R and Muller M: Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366: 80-85, 2004.